3D Spine Matrix Biotechnologie GmbH

Founded

2016

Staff

2

Organization type

RDM biotech/pharma

Region

Lower Austria

Focus

human health

Focus

other

Sales/Distribution:The company conservatively assumes that the general rate of substitution using disc-maintaining therapy will be 10% of the market. This would lead to a market potential of approx. 30.000 applications. With an average implant price of € 1.770, as attained according to company assumptions, this results in a adressable market potential in Europe of at least € 53 million.